SCHEMBL4925985

SCHEMBL4925985

CC(=O)OCC[C@H](CBr)OC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.41
ALDH1A1 P00352 3/20 0.39
TSHR P16473 3/20 0.38
CHRM5 P08912 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PGR P06401 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
HTR1A P08908 1/20 0.38
CHRNB2 P17787 1/20 0.38
TBXA2R P21731 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
CHRNA10 Q9GZZ6 1/20 0.38
CHRNA9 Q9UGM1 1/20 0.38
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4918620 1.00 ALOX15 (0.41) ALOX15ALDH1A1TSHRCHRM5CHRM1
SCHEMBL4918612 1.00 ALOX15 (0.41) ALOX15ALDH1A1TSHRCHRM5CHRM1
SCHEMBL13825187 0.90 ALOX15 (0.44) ALOX15ALDH1A1TSHRCHRM5CHRM1
SCHEMBL11913587 0.82 ALDH1A1 (0.45) ALOX15ALDH1A1TSHRCHRM5CHRM1
SCHEMBL7757645 0.82 PRKCA (0.44) ALOX15ALDH1A1TSHRCHRM5CHRM1
SCHEMBL18652575 0.82 TDP1 (0.47) ALOX15ALDH1A1TSHRCHRM5CHRM1
SCHEMBL4922132 0.81 TSHR (0.39) ALOX15TSHRCHRM1SMN1; SMN2CHRM2
SCHEMBL4930526 0.81 TSHR (0.39) ALOX15TSHRCHRM1SMN1; SMN2CHRM2
SCHEMBL4922117 0.81 TSHR (0.39) ALOX15TSHRCHRM1SMN1; SMN2CHRM2
SCHEMBL1116238 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7390825-B1 Process for the preparation of oxazolidinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2008-06-24 US disclosed
US-20080146458-A1 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2008-06-19 US disclosed
US-20070265451-A1 Process for the preparation of oxazolidinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265451-A1 Process for the preparation of oxazolidinones and method of use thereof OXA1L, OTC, ODC1 ALOX15 1542/4885ALDH1A1 2186/4885TSHR 4618/4885
US-20080146458-A1 PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF OXA1L, OGFOD1, CYP51A1 ALOX15 1647/4885ALDH1A1 1117/4885TSHR 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.